Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A phase I study of the GM-CSF antagonist E21R.
Olver IN, Hercus T, Lopez A, Vadas M, Somogyi AA, Doyle I, Foster DJ, Keefe D, Taylor A, Brown M, To LB, Cole J, Rawling T, Cambareri B, Myers M, Olszewski N, Bastiras S, Senn C, Hey A, Verma M, Wigley P. Olver IN, et al. Cancer Chemother Pharmacol. 2002 Sep;50(3):171-8. doi: 10.1007/s00280-002-0474-y. Epub 2002 Jul 3. Cancer Chemother Pharmacol. 2002. PMID: 12203098 Clinical Trial.
Gastrointestinal mucositis.
Keefe DM, Gibson RJ, Hauer-Jensen M. Keefe DM, et al. Semin Oncol Nurs. 2004 Feb;20(1):38-47. doi: 10.1053/j.soncn.2003.10.007. Semin Oncol Nurs. 2004. PMID: 15038516 Review.
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.
Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST; Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Rubenstein EB, et al. Cancer. 2004 May 1;100(9 Suppl):2026-46. doi: 10.1002/cncr.20163. Cancer. 2004. PMID: 15108223
106 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page